BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Prognosis
307 results:

  • 1. Analysis of clinicopathologic and imaging features of dual-phenotype hepatocellular carcinoma.
    Huang K; He Y; Liang T; Mo S; Liao Y; Gao Q; Liao X; Han C; Zhu G; Peng T
    Sci Rep; 2024 Feb; 14(1):3314. PubMed ID: 38332165
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic liver Classification B) Receiving Systemic Therapy.
    Ielasi L; Stefanini B; Conti F; Tonnini M; Tortora R; Magini G; Sacco R; Pressiani T; Trevisani F; Foschi FG; Piscaglia F; Granito A; Tovoli F
    Curr Oncol; 2024 Jan; 31(1):547-557. PubMed ID: 38275831
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
    Shan YY; Wang CN; Mao SQ; Yu X; Sun JN; Lu CD
    Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1318-1325. PubMed ID: 38253077
    [No Abstract]    [Full Text] [Related]  

  • 4. Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B.
    Kim TH; Kim JH; Yim HJ; Seo YS; Yim SY; Lee YS; Jung YK; Yeon JE; Um SH; Byun KS
    Gut Liver; 2024 Mar; 18(2):305-315. PubMed ID: 38213189
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Is Precision Surgery Applicable to Colorectal liver Metastases? A Systematic Review and Meta-analysis of Studies that Investigate the Association of Surgical Technique with Outcomes in the Context of Distinct Tumor Biology.
    Pikoulis E; Papaconstantinou D; Pikouli A; Pararas N; Buettner S; Wang J; Stasinos G; Belias M; Dellaportas D; Pozios I; Antoniou E; Beyer K; Kreis ME; Pawlik TM; Margonis GA
    Ann Surg Oncol; 2024 Mar; 31(3):1823-1832. PubMed ID: 38155339
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion.
    Chang CJ; Hsu WF; Jeng LB; Lai HC; Hsu SC; Chen TH; Wang HW; Peng CY
    Curr Oncol; 2023 Nov; 30(12):10134-10141. PubMed ID: 38132371
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Adhesion G Protein-Coupled Receptor G2 Promotes Hepatocellular Carcinoma Progression and Serves as a Neutrophil-Related Prognostic Biomarker.
    Wu Q; Wang P; Peng Q; Kang Z; Deng Y; Li J; Chen Y; Li J; Ge F
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069309
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors.
    Zeng ZX; Wu JY; Wu JY; Li YN; Fu YK; Zhang ZB; Liu DY; Li H; Ou XY; Zhuang SW; Yan ML
    Hepatol Int; 2024 Apr; 18(2):651-660. PubMed ID: 38040945
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data.
    Zou Y; Yue M; Jia L; Wang Y; Chen H; Zhang A; Xia X; Liu W; Yu R; Yang S; Huang P
    BMC Cancer; 2023 Nov; 23(1):1147. PubMed ID: 38007418
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
    Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
    Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Overexpression of Nei endonuclease VIII-like protein 3 in hepatocellular carcinoma indicates increased levels of immune infiltration and an unfavorable prognosis].
    Wang GN; Zhang YP; Wang MC; Han W; Zhang YC
    Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):986-995. PubMed ID: 37872095
    [No Abstract]    [Full Text] [Related]  

  • 12. cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.
    He S; Xia C; Li H; Cao M; Yang F; Yan X; Zhang S; Teng Y; Li Q; Chen W
    Sci China Life Sci; 2024 Jan; 67(1):122-131. PubMed ID: 37755589
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Preoperative MRI features to predict vessels that encapsulate tumor clusters and microvascular invasion in hepatocellular carcinoma.
    Zhu Y; Yang L; Wang M; Pan J; Zhao Y; Huang H; Sun K; Chen F
    Eur J Radiol; 2023 Oct; 167():111089. PubMed ID: 37713969
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases.
    Liao L; Sun H; He J; Liu Y; Pan Z; Wu X; Fan W; Peng J; Li C
    BMC Surg; 2023 Sep; 23(1):271. PubMed ID: 37689651
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resection.
    Xie Q; Zhao Z; Yang Y; Long D; Luo C
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14983-14996. PubMed ID: 37606762
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification.
    Fan Z; Jin M; Zhang L; Wang N; Li M; Wang C; Wei F; Zhang P; Du X; Sun X; Qiu W; Wang M; Wang H; Shi X; Ye J; Jiang C; Zhou J; Chai W; Qi J; Li T; Zhang R; Liu X; Huang B; Chai K; Cao Y; Mu W; Huang Y; Yang T; Zhang H; Qu L; Liu Y; Wang G; Lv G
    Gut; 2023 Nov; 72(11):2149-2163. PubMed ID: 37549980
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Exploring the molecular pathogenesis, diagnosis and treatment of fibrolamellar hepatocellular carcinoma: A state of art review of the current literature.
    Alshareefy Y; Shen CY; Prekash RJ
    Pathol Res Pract; 2023 Aug; 248():154655. PubMed ID: 37429175
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Risk factors and survival prediction of young breast cancer patients with liver metastases: a population-based study.
    Pu CC; Yin L; Yan JM
    Front Endocrinol (Lausanne); 2023; 14():1158759. PubMed ID: 37424855
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients.
    Lin KY; Lin ZW; Chen QJ; Luo LP; Zhang JX; Chen JH; Wang K; Tai S; Zhang ZB; Wang SF; Zhang JY; You WY; Wang B; You PH; Lin KC; Yang T; Zeng YY
    Hepatol Int; 2023 Dec; 17(6):1477-1489. PubMed ID: 37382760
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Radiographic duodenal invasion is associated with poor prognosis and early recurrence in patients with pancreatic ductal adenocarcinoma.
    Miyazawa M; Hirono S; Kawai M; Okada KI; Kitahata Y; Motobayashi H; Sato M; Yoshimura T; Ueno M; Hayami S; Miyamoto A; Shimizu A; Yamaue H
    Eur J Surg Oncol; 2023 Oct; 49(10):106960. PubMed ID: 37353425
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.